Praktické lekárnictvo 1/2013
The current therapeutic options for relapsing-remiting form of multiple sclerosis
Multiple sclerosis is one of the autoimmune, inflammatory diseases affecting myelin of the central nervous system (1). It belongs between the most common chronic, non-traumatic neurological disease of young productive people and has many forms. The initial phase is the relapsing-remitting form which can be influenced by pharmacology – immunomodulatory therapy (2). It is true that MS is not yet curable disease, but it is medicable disease because current options of pharmacotherapy are preventing progression of the disease and ensure a higher quality of patient life (1).
Keywords: multiple sclerosis, patient with relapsing-remitting form, immunomodulatory therapy.
